NCT05521503 Biopsy Collection and Repository Database
| NCT ID | NCT05521503 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kenneth S. Campbell |
| Condition | Cardiovascular Diseases |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2021-12-21 |
| Primary Completion | 2030-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2021-12-21 with a primary completion date of 2030-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Use samples procured from patients to improve understanding of molecular, cellular, and tissue-level processes produced by a variety of cardiac diseases and therapeutic interventions.
Eligibility Criteria
Inclusion Criteria: * All patients undergoing evaluation of a cardiac condition or receiving a right heart catheterization with biopsy clinically indicated who are at least 18 years of age. Exclusion Criteria: * Patients without a cardiovascular or amyloidosis diagnosis, under 18 years of age.
Contact & Investigator
Kenneth S Campbell, PhD
PRINCIPAL INVESTIGATOR
University of Kentucky
Frequently Asked Questions
Who can join the NCT05521503 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiovascular Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05521503 currently recruiting?
Yes, NCT05521503 is actively recruiting participants. Contact the research team at k.s.campbell@uky.edu for enrollment information.
Where is the NCT05521503 trial being conducted?
This trial is being conducted at Lexington, United States.
Who is sponsoring the NCT05521503 clinical trial?
NCT05521503 is sponsored by Kenneth S. Campbell. The principal investigator is Kenneth S Campbell, PhD at University of Kentucky. The trial plans to enroll 400 participants.